首頁 > 市場調查報告書 > 醫療設備

放射性栓塞治療市場規模、佔有率和成長分析：按設備、適應症、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

1964420

放射性栓塞治療市場規模、佔有率和成長分析：按設備、適應症、最終用戶和地區分類－2026-2033年產業預測

Radioembolization Therapy Market Size, Share, and Growth Analysis, By Device Type (Chemoembolization Devices, Radioactive Beads), By Indication (Liver Cancer, Colorectal Cancer), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球放射性栓塞治療市場價值為13億美元，預計將從2025年的14.4億美元成長到2033年的31.7億美元。預測期（2026-2033年）的複合年成長率預計為10.4%。

全球放射性栓塞治療市場受到原發性和轉移性肝癌發病率上升以及患者對標靶性、微創局部治療日益成長的需求的顯著影響。該市場涵蓋各種設備，包括裝置、微球、輸送導管和治療計劃軟體，這些設備能夠將釔-90等放射性微球輸送到肝腫瘤部位，與傳統化療相比，顯著提高患者的生存率和生活品質。劑量測定、影像和導管設計方面的技術進步推動了臨床應用的普及，而診斷影像技術的改進和個人化劑量測定則提高了治療的精確度。有利的醫保改革、強力的臨床證據以及亞太地區的市場擴張，都為該行業帶來了積極影響。此外，放射性栓塞與免疫療法的結合正在創造新的治療機會，推動市場成長，並加劇供應商和製造商之間的競爭。

全球放射性栓塞治療市場促進因素

隨著肝腫瘤發生率的不斷上升，臨床上對標靶局部治療的需求日益成長，醫療機構正加速將放射乳化技術整合到治療通訊協定中。由於難以手術治療的腫瘤患者數量不斷增加，人們越來越傾向於尋求在控制腫瘤的同時盡可能保留肝功能的替代療法。這種轉變促使治療中心加強對必要設備的投入並加強人員訓練。此外，轉診量的增加以及包括腫瘤內科醫生和介入放射科醫生在內的各專科醫生之間合作的加強，凸顯了放射乳化技術的治療優勢，並進一步推動了市場成長和服務的普及。

全球放射性栓塞治療市場的限制因素

全球放射乳化治療市場面臨許多挑戰，包括高昂的治療費用和複雜的物流，這些都是阻礙其普及的主要障礙。這些因素對醫療機構和服務網路而言構成了巨大的進入門檻。對專用設備、耗材和設施維修的需求，以及對訓練有素的多學科團隊的依賴，往往使規模小規模的醫療中心難以提供放射乳化服務。此外，與排班、供應鏈管理以及腫瘤科、放射科和護理人員之間的協調相關的運營複雜性，也增加了行政負擔，進一步阻礙了市場的快速擴張，並導致市場集中於大規模醫療機構。

放射乳劑治療市場的全球趨勢

全球放射乳化治療市場正呈現出精準患者篩選的顯著趨勢，這極大地影響著治療通訊協定並推動了市場需求。對患者細分的日益重視使臨床醫生能夠進行多學科評估，並利用生物標記數據和先進的影像技術來識別最佳治療候選者。這種個人化治療方案不僅改善了臨床療效，也提升了治療的價值認知，並有助於將其整合到複雜的診療路徑中。此外，針對醫療專業人員的培訓和決策支援工具的開發也推動了市場成長，增強了相關人員的信心，並強化了個人化癌症治療框架內的轉診模式。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Boston Scientific Corporation
CeloNova BioSciences
Sensus Healthcare
Merz Pharmaceuticals
Biocompatibles
Sirtex Medical Limited
GRAIL, Inc.
Terumo Corporation
BTG International
Medtronic
ArcherDX
Curium
Nano-X Imaging
Varian Medical Systems
Elekta
Innova Medical
Epigenetics
AtriCure
GE Healthcare
Siemens Healthineers

結論與建議

簡介目錄

Product Code: SQMIG35D2391

Global Radioembolization Therapy Market size was valued at USD 1.3 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 3.17 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

The global radioembolization therapy market is significantly influenced by the rising prevalence of primary and metastatic liver cancers, alongside the growing preference for targeted, minimally invasive locoregional treatments. Comprising devices, microspheres, delivery catheters, and planning software, this market facilitates the administration of radioactive microspheres like yttrium-90 to hepatic tumors, offering notable survival and quality-of-life advantages over traditional chemotherapy. Technological advancements in dosimetry, imaging, and catheter design have fostered greater clinical adoption, while improved diagnostic imaging and personalized dosimetry enhance treatment precision. The sector benefits from favorable reimbursement reforms, strong clinical evidence, and market expansion into Asia Pacific. Additionally, combining radioembolization with immunotherapies generates new treatment opportunities, increasing market growth and competitiveness among providers and manufacturers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radioembolization Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radioembolization Therapy Market Segments Analysis

Global radioembolization therapy market is segmented by device type, indication, end user and region. Based on device type, the market is segmented into Chemoembolization Devices, Radioactive Beads and Delivery Systems. Based on indication, the market is segmented into Liver Cancer, Colorectal Cancer and Other Tumors. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Radioembolization Therapy Market

The growing incidence of liver tumors is driving a heightened clinical demand for targeted locoregional therapies, prompting healthcare providers to incorporate radioembolization into their treatment protocols. With an increasing number of patients presenting with tumors that are not viable for surgical intervention, there is a significant shift towards exploring alternative therapies that prioritize tumor management while maintaining liver functionality. This shift encourages treatment centers to invest in necessary equipment and staff training. Additionally, the trend of increased referrals and collaborative efforts among specialists, including oncologists and interventional radiologists, underscores the therapeutic advantages of radioembolization, further propelling market growth and service availability.

Restraints in the Global Radioembolization Therapy Market

The Global Radioembolization Therapy market faces significant challenges due to high procedural costs and intricate logistics, which act as major barriers to widespread adoption. These factors impose considerable entry hurdles for healthcare providers and service networks. The substantial capital investment required for specialized equipment, consumables, and facility modifications, coupled with the necessity for well-trained multidisciplinary teams, often discourages smaller medical centers from offering radioembolization services. Additionally, the operational complexities related to scheduling, supply chain management, and coordinating efforts among oncology, radiology, and nursing staff increase administrative workload, further hindering rapid expansion and leading to market concentration in larger institutions.

Market Trends of the Global Radioembolization Therapy Market

The Global Radioembolization Therapy market is witnessing a notable trend towards precision patient selection, which is significantly influencing treatment protocols and driving demand. Increased focus on refined patient stratification enables clinicians to engage in multidisciplinary evaluations and leverage advanced imaging techniques alongside biomarker data to identify optimal candidates for therapy. This tailored approach not only enhances clinical outcomes but also boosts the perceived value of treatment, facilitating its integration into complex care pathways. Furthermore, the market growth is underpinned by the development of provider training and decision support tools, fostering confidence among stakeholders and enhancing referral patterns within personalized oncology frameworks.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Radioembolization Therapy Market Size by Device Type & CAGR (2026-2033)

Market Overview
Chemoembolization Devices
Radioactive Beads
Delivery Systems

Global Radioembolization Therapy Market Size by Indication & CAGR (2026-2033)

Market Overview
Liver Cancer
Colorectal Cancer
Other Tumors

Global Radioembolization Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Radioembolization Therapy Market Size & CAGR (2026-2033)

North America (Device Type, Indication, End User)
- US
- Canada
Europe (Device Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Indication, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CeloNova BioSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sensus Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merz Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocompatibles
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sirtex Medical Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GRAIL, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTG International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArcherDX
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano-X Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innova Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epigenetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments